Zhiyong Luo

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

Janeta Popovici-Müller, René M. Lemieux, Erin Artin et al. · ACS Medicinal Chemistry Letters · 2018 · 422 citations · Full text

Idh1 Mutant Cancers, Somatic Point Mutations, Somatic Variant +14

Fluorous Mixture Synthesis: A Fluorous-Tagging Strategy for the Synthesis and Separation of Mixtures of Organic Compounds

Zhiyong Luo, Qisheng Zhang, Yoji Oderaotoshi et al. · Science · 2001 · 297 citations

Combinatorial Chemistry, Engineering, Organic Chemistry +17

Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma

Zenon Konteatis, Erin Artin, Brandon Nicolay et al. · ACS Medicinal Chemistry Letters · 2020 · 174 citations · Full text

Mutant Isocitrate Dehydrogenase, High-grade Gliomas, Glioma +18

Fluorous Synthesis with Fewer Fluorines (Light Fluorous Synthesis):  Separation of Tagged from Untagged Products by Solid-Phase Extraction with Fluorous Reverse-Phase Silica Gel

Dennis P. Curran, Zhiyong Luo · Journal of the American Chemical Society · 1999 · 172 citations

Solvent Extraction, Engineering, Fewer Fluorines +16

PgMYB2, a MeJA-Responsive Transcription Factor, Positively Regulates the Dammarenediol Synthase Gene Expression in Panax Ginseng

Tuo Liu, Tiao Luo, Xiangqian Guo et al. · International Journal of Molecular Sciences · 2019 · 133 citations · Full text